MAGE-9 Polyclonal Antibody

MAGEA9 is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita.

Introducing the MAGE-9 Polyclonal Antibody, a cutting-edge immunological tool designed to facilitate accurate and efficient detection of MAGE-9 protein expression. This meticulously crafted antibody is meticulously developed using state-of-the-art techniques, ensuring exceptional specificity and sensitivity in a wide range of applications.

The MAGE-9 Polyclonal Antibody is meticulously purified from high-quality sources, guaranteeing optimal performance and reproducibility. Its exceptional affinity for the MAGE-9 protein enables precise identification and quantification, making it an invaluable asset for researchers and clinicians alike.

With its versatile nature, the MAGE-9 Polyclonal Antibody is suitable for various experimental methodologies, including Western blotting, immunohistochemistry, and immunofluorescence. Its robust performance across multiple platforms ensures reliable and consistent results, empowering researchers to delve deeper into the intricate mechanisms involving MAGE-9 protein.

This antibody's exceptional specificity and sensitivity make it an indispensable tool for cancer research, as MAGE-9 protein has been implicated in various malignancies. By accurately detecting and quantifying MAGE-9 expression, researchers can gain valuable insights into its role in tumorigenesis, potentially paving the way for novel therapeutic interventions.

The MAGE-9 Polyclonal Antibody is meticulously validated through rigorous quality control measures, ensuring its reliability and reproducibility. Its exceptional performance is further enhanced by its long shelf life, allowing for prolonged usage without compromising its efficacy.

In summary, the MAGE-9 Polyclonal Antibody represents a breakthrough in immunological research, offering unparalleled specificity, sensitivity, and versatility. With its exceptional performance and reliability, this antibody is poised to revolutionize the field of cancer research, enabling scientists to unravel the complexities of MAGE-9 protein and its implications in tumorigenesis.